Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2019

01-05-2019 | Chronic Kidney Disease | Original article

Effect of exercise intensity on renal blood flow in patients with chronic kidney disease stage 2

Authors: Kazuko Kotoku, Tetsuhiko Yasuno, Shotaro Kawakami, Kanta Fujimi, Takuro Matsuda, Shihoko Nakashima, Yoshinari Uehara, Hiroaki Tanaka, Takao Saito, Yasuki Higaki

Published in: Clinical and Experimental Nephrology | Issue 5/2019

Login to get access

Abstract

Background

Acute exercise reduces renal blood flow (RBF). However, the effect of exercise intensity on RBF in patients with chronic kidney disease (CKD) stage 2 is not known. We investigated the association between RBF and exercise intensity in patients with CKD stage 2 using pulsed Doppler ultrasonography.

Methods

Eight men with CKD stage 2 (cystatin C-based estimate of glomerular filtration rate: 60–89 ml/min/1.73 m2) participated in this study. Using a bicycle ergometer, participants undertook a maximal graded exercise test (MGET) (experiment 1) and a multi-stage exercise test (experiment 2) to determine their lactate threshold (LT). Participants undertook a multi-stage exercise test for 4-min each. Workloads of 60%, 80%, 100%, 120%, and 140% of LT were used in experiment 3. RBF was measured by pulsed Doppler ultrasonography at rest, immediately after exercise, and 1 h after exercise in experiment 1, and at rest and immediately after each exercise bout in experiment 3.

Results

Renal blood flow after the MGET was 52% lower than at rest, and did not recover as well as after the exercise test. Cross-sectional area (CSA) was significantly lower after graded exercise. RBF tended to be lower at 100% of LT and was significantly lower at 120% of LT. CSA was significantly lower at 100% of LT.

Conclusions

Renal blood flow does not change during exercise until the LT is reached. These findings may assist in making appropriate exercise recommendations to patients with CKD stage 2.
Literature
1.
go back to reference Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156–163.CrossRefPubMed Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156–163.CrossRefPubMed
2.
go back to reference Japanese Society of Nephrology. Evidence-based clinical practice guideline for CKD 2013. Clin Exp Nephrol. 2014;18:346–423.CrossRef Japanese Society of Nephrology. Evidence-based clinical practice guideline for CKD 2013. Clin Exp Nephrol. 2014;18:346–423.CrossRef
3.
go back to reference Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–95.CrossRefPubMed Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–95.CrossRefPubMed
4.
go back to reference Michishita R, Matsuda T, Kawakami S, Kiyonaga A, Tanaka H, Morito N, Higaki Y. The association between unhealthy lifestyle behaviors and the prevalence of chronic kidney disease (CKD) in middle-aged and older men. J Epidemiol. 2016;26:378–85.CrossRefPubMed Michishita R, Matsuda T, Kawakami S, Kiyonaga A, Tanaka H, Morito N, Higaki Y. The association between unhealthy lifestyle behaviors and the prevalence of chronic kidney disease (CKD) in middle-aged and older men. J Epidemiol. 2016;26:378–85.CrossRefPubMed
5.
go back to reference Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T. Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009;4:1901–6.CrossRefPubMedPubMedCentral Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T. Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009;4:1901–6.CrossRefPubMedPubMedCentral
6.
go back to reference Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Tamura MK, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–35.CrossRefPubMed Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Tamura MK, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–35.CrossRefPubMed
7.
go back to reference National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60:850–86.CrossRef National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60:850–86.CrossRef
8.
9.
go back to reference Castenfors J. Renal function during exercise. Acta Physiol Scand. 1967;70(Suppl. 293):1–44. Castenfors J. Renal function during exercise. Acta Physiol Scand. 1967;70(Suppl. 293):1–44.
10.
11.
go back to reference Grimby G. Renal clearances during prolonged supine exercise at different loads. J Appl Physiol. 1965;20:1294–8.CrossRef Grimby G. Renal clearances during prolonged supine exercise at different loads. J Appl Physiol. 1965;20:1294–8.CrossRef
12.
go back to reference Suzuki M. Physical exercise and renal function. J Phys Fit Sports Med. 2015;4:17–29.CrossRef Suzuki M. Physical exercise and renal function. J Phys Fit Sports Med. 2015;4:17–29.CrossRef
14.
go back to reference Johansen KL. Exercise and chronic kidney disease current recommendations. Sport Med. 2005;35:485–99.CrossRef Johansen KL. Exercise and chronic kidney disease current recommendations. Sport Med. 2005;35:485–99.CrossRef
15.
go back to reference Kirkman D, Edwards DG, Lennon-Edwards S. Exercise as an adjunct therapy in chronic kidney disease. Renal Nutr Forum. 2014;33:1–8.PubMedPubMedCentral Kirkman D, Edwards DG, Lennon-Edwards S. Exercise as an adjunct therapy in chronic kidney disease. Renal Nutr Forum. 2014;33:1–8.PubMedPubMedCentral
16.
17.
go back to reference Momen A, Leuenberger UA, Ray CA, Cha S, Handly B, Sinoway LI. Renal vascular responses to static handgrip: role of muscle mechanoreflex. Am J Physiol Heart Circ Physiol. 2003;285:H1247–53.CrossRefPubMed Momen A, Leuenberger UA, Ray CA, Cha S, Handly B, Sinoway LI. Renal vascular responses to static handgrip: role of muscle mechanoreflex. Am J Physiol Heart Circ Physiol. 2003;285:H1247–53.CrossRefPubMed
18.
go back to reference Momen A, Bower D, Leuenberger UA, Boehmer J, Lerner S, Alfrey EJ, Handly B, Sinoway LI. Renal vascular response to static handgrip exercise: sympathetic vs. autoregulatory control. Am J Physiol Heart Circ Physiol. 2005;289:H1770–6.CrossRefPubMed Momen A, Bower D, Leuenberger UA, Boehmer J, Lerner S, Alfrey EJ, Handly B, Sinoway LI. Renal vascular response to static handgrip exercise: sympathetic vs. autoregulatory control. Am J Physiol Heart Circ Physiol. 2005;289:H1770–6.CrossRefPubMed
19.
go back to reference Endo MY, Suzuki R, Nagahata N, Hayashi N, Miura A, Koga S, Fukuba Y. Differential arterial blood flow response of splanchnic and renal organs during low-intensity cycling exercise in women. Am J Physiol Heart Circ Physiol. 2008;294:H2322–6.CrossRefPubMed Endo MY, Suzuki R, Nagahata N, Hayashi N, Miura A, Koga S, Fukuba Y. Differential arterial blood flow response of splanchnic and renal organs during low-intensity cycling exercise in women. Am J Physiol Heart Circ Physiol. 2008;294:H2322–6.CrossRefPubMed
20.
go back to reference Lesley AS, Josef C, Christopher HS, Harold IF, Marc F, John K, Jerome R, Frederick VL, Robert DB, Yaping Z, Tom G, Andrew SL. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395–406.CrossRef Lesley AS, Josef C, Christopher HS, Harold IF, Marc F, John K, Jerome R, Frederick VL, Robert DB, Yaping Z, Tom G, Andrew SL. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395–406.CrossRef
21.
go back to reference Horio M, Imai E, Yasuda Y, Matsuo S, et al. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61(2):197–203.CrossRef Horio M, Imai E, Yasuda Y, Matsuo S, et al. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61(2):197–203.CrossRef
22.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.CrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.CrossRef
23.
go back to reference Suzuki M. Exercise and renal function. Adv Ex Sports Physiol. 1996;2:45–56. Suzuki M. Exercise and renal function. Adv Ex Sports Physiol. 1996;2:45–56.
24.
go back to reference Ueda J, Nakanishi H, Miyazaki M. Effects of glucagon on the renal hemodynamics of dogs. Jpn Circ J. 1977;41:991–6.CrossRefPubMed Ueda J, Nakanishi H, Miyazaki M. Effects of glucagon on the renal hemodynamics of dogs. Jpn Circ J. 1977;41:991–6.CrossRefPubMed
25.
go back to reference Monika JB, et al. Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans. Eur J Endocrinol. 2014;170:529–38.CrossRef Monika JB, et al. Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans. Eur J Endocrinol. 2014;170:529–38.CrossRef
26.
go back to reference Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens. 1988;1:335–47.CrossRef Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens. 1988;1:335–47.CrossRef
27.
go back to reference Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76:612–9.CrossRefPubMedPubMedCentral Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76:612–9.CrossRefPubMedPubMedCentral
28.
go back to reference Tanaka H, Shindo M, Gutkowska J, Kinoshita A, Urata H, Ikeda M, Arakawa K. Effect of acute exercise on plasma immunoreactive—Atrial natriuretic factor. Life Sci. 1986;39:1685–93.CrossRefPubMed Tanaka H, Shindo M, Gutkowska J, Kinoshita A, Urata H, Ikeda M, Arakawa K. Effect of acute exercise on plasma immunoreactive—Atrial natriuretic factor. Life Sci. 1986;39:1685–93.CrossRefPubMed
29.
go back to reference Sanders LR. Exercise-induced acute renal failure associated with ibuprofen, hydrochlorothiazide, and triamterene. J Am Soc Nephrol. 1995;5:2020–3.PubMed Sanders LR. Exercise-induced acute renal failure associated with ibuprofen, hydrochlorothiazide, and triamterene. J Am Soc Nephrol. 1995;5:2020–3.PubMed
Metadata
Title
Effect of exercise intensity on renal blood flow in patients with chronic kidney disease stage 2
Authors
Kazuko Kotoku
Tetsuhiko Yasuno
Shotaro Kawakami
Kanta Fujimi
Takuro Matsuda
Shihoko Nakashima
Yoshinari Uehara
Hiroaki Tanaka
Takao Saito
Yasuki Higaki
Publication date
01-05-2019
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 5/2019
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-01685-3

Other articles of this Issue 5/2019

Clinical and Experimental Nephrology 5/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.